Cargando…
An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks i...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239435/ https://www.ncbi.nlm.nih.gov/pubmed/34211464 http://dx.doi.org/10.3389/fimmu.2021.665312 |
_version_ | 1783715077008916480 |
---|---|
author | Davies, James Vallejo, Andres F. Sirvent, Sofia Porter, Gemma Clayton, Kalum Qumbelo, Yamkela Stumpf, Patrick West, Jonathan Gray, Clive M. Chigorimbo-Murefu, Nyaradzo T. L. MacArthur, Ben Polak, Marta E. |
author_facet | Davies, James Vallejo, Andres F. Sirvent, Sofia Porter, Gemma Clayton, Kalum Qumbelo, Yamkela Stumpf, Patrick West, Jonathan Gray, Clive M. Chigorimbo-Murefu, Nyaradzo T. L. MacArthur, Ben Polak, Marta E. |
author_sort | Davies, James |
collection | PubMed |
description | Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments. |
format | Online Article Text |
id | pubmed-8239435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82394352021-06-30 An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells Davies, James Vallejo, Andres F. Sirvent, Sofia Porter, Gemma Clayton, Kalum Qumbelo, Yamkela Stumpf, Patrick West, Jonathan Gray, Clive M. Chigorimbo-Murefu, Nyaradzo T. L. MacArthur, Ben Polak, Marta E. Front Immunol Immunology Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments. Frontiers Media S.A. 2021-06-15 /pmc/articles/PMC8239435/ /pubmed/34211464 http://dx.doi.org/10.3389/fimmu.2021.665312 Text en Copyright © 2021 Davies, Vallejo, Sirvent, Porter, Clayton, Qumbelo, Stumpf, West, Gray, Chigorimbo-Murefu, MacArthur and Polak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Davies, James Vallejo, Andres F. Sirvent, Sofia Porter, Gemma Clayton, Kalum Qumbelo, Yamkela Stumpf, Patrick West, Jonathan Gray, Clive M. Chigorimbo-Murefu, Nyaradzo T. L. MacArthur, Ben Polak, Marta E. An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title | An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title_full | An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title_fullStr | An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title_full_unstemmed | An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title_short | An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells |
title_sort | irf1-irf4 toggle-switch controls tolerogenic and immunogenic transcriptional programming in human langerhans cells |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239435/ https://www.ncbi.nlm.nih.gov/pubmed/34211464 http://dx.doi.org/10.3389/fimmu.2021.665312 |
work_keys_str_mv | AT daviesjames anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT vallejoandresf anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT sirventsofia anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT portergemma anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT claytonkalum anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT qumbeloyamkela anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT stumpfpatrick anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT westjonathan anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT grayclivem anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT chigorimbomurefunyaradzotl anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT macarthurben anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT polakmartae anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT daviesjames irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT vallejoandresf irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT sirventsofia irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT portergemma irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT claytonkalum irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT qumbeloyamkela irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT stumpfpatrick irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT westjonathan irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT grayclivem irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT chigorimbomurefunyaradzotl irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT macarthurben irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells AT polakmartae irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells |